The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions
<i>Background and Objectives</i>: Available evidence reports the overexpression of β1 integrin in dysplastic rather than normal cervical tissue. We aimed to evaluate the involvement of β1 (CD29) integrin in the progressive pathogenesis of cervical intraepithelial neoplasia (CIN). <i&g...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-02-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/3/364 |
| _version_ | 1797240139990171648 |
|---|---|
| author | Maria Teresa Schettino Eleonora Petra Preti Valeria Vietri Nadia Agrillo Nicola Iavazzo Diego Domenico Fasulo Pasquale De Franciscis Maria Rosaria Campitiello Maria Giovanna Vastarella Gaetano Riemma Barbara Gardella Filippo Murina |
| author_facet | Maria Teresa Schettino Eleonora Petra Preti Valeria Vietri Nadia Agrillo Nicola Iavazzo Diego Domenico Fasulo Pasquale De Franciscis Maria Rosaria Campitiello Maria Giovanna Vastarella Gaetano Riemma Barbara Gardella Filippo Murina |
| author_sort | Maria Teresa Schettino |
| collection | DOAJ |
| description | <i>Background and Objectives</i>: Available evidence reports the overexpression of β1 integrin in dysplastic rather than normal cervical tissue. We aimed to evaluate the involvement of β1 (CD29) integrin in the progressive pathogenesis of cervical intraepithelial neoplasia (CIN). <i>Materials and Methods</i>: From January 2019 to December 2021, we prospectively enrolled women undergoing a colposcopy with a cervical biopsy for abnormal cervical cytology and/or undefined cytology with a positive HPV DNA test and women with relapsing cervical inflammatory disorders. Based on the histopathological results, women were divided into four groups: group A (CIN1), group B (CIN2), group C (CIN3), and group D (no CIN diagnosis) as a control group. Subsequently, cytofluorimetry and immunohistochemical analysis (based on the identified positive cell ratios as follows: ≤10%, negative; 10–25%, 1+ (weak); 25–50%, 2+ (medium); ≥50%, and 3+ (high)) for β1 integrin were carried out. <i>Results</i>: In total, 154 women were included. The average fluorescence intensity in the four groups was 2.35 ± 1.37, 2.73 ± 1.56, 3.09 ± 1.56, and 2.13 ± 1.25 UA from groups A to D, respectively; this figure was significantly different for CIN3 (group C) women relative to the other groups (<i>p</i> = 0.0132). Higher β1 integrin/CD29 concentrations in the CIN groups with HR-HPV 16 and 18 were also detected (<i>p</i> = 0.0292, 0.0367, and 0.0357 respectively for CIN3, CIN2, and CIN1). Immunohistochemistry analysis showed higher results for the CIN3 group compared to controls and all the other groups (<i>p</i> < 0.001). <i>Conclusions</i>: β1/CD29 integrin expression increased with CIN grade, and it was significantly higher in CIN3 lesions. This could be used as a promising screening tool to identify women prone to developing high-grade cervical lesions. However, additional evidence is needed to strengthen these findings. |
| first_indexed | 2024-04-24T18:02:41Z |
| format | Article |
| id | doaj.art-7c5431ac8b844d8188adc7491d31e9e6 |
| institution | Directory Open Access Journal |
| issn | 1010-660X 1648-9144 |
| language | English |
| last_indexed | 2024-04-24T18:02:41Z |
| publishDate | 2024-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Medicina |
| spelling | doaj.art-7c5431ac8b844d8188adc7491d31e9e62024-03-27T13:53:24ZengMDPI AGMedicina1010-660X1648-91442024-02-0160336410.3390/medicina60030364The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated LesionsMaria Teresa Schettino0Eleonora Petra Preti1Valeria Vietri2Nadia Agrillo3Nicola Iavazzo4Diego Domenico Fasulo5Pasquale De Franciscis6Maria Rosaria Campitiello7Maria Giovanna Vastarella8Gaetano Riemma9Barbara Gardella10Filippo Murina11Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyPreventive Gynecology Unit, European Institute of Oncology, 20100 Milano, ItalyDepartment of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyASL Salerno, 84100 Salerno, ItalyDepartment of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, ItalyDepartment of Obstetrics and Gynecology, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, ItalyLower Genital Tract Disease Unit, Obstetrics and Gynecology Department, V. Buzzi Hospital, University of Milan, 20154 Milan, Italy<i>Background and Objectives</i>: Available evidence reports the overexpression of β1 integrin in dysplastic rather than normal cervical tissue. We aimed to evaluate the involvement of β1 (CD29) integrin in the progressive pathogenesis of cervical intraepithelial neoplasia (CIN). <i>Materials and Methods</i>: From January 2019 to December 2021, we prospectively enrolled women undergoing a colposcopy with a cervical biopsy for abnormal cervical cytology and/or undefined cytology with a positive HPV DNA test and women with relapsing cervical inflammatory disorders. Based on the histopathological results, women were divided into four groups: group A (CIN1), group B (CIN2), group C (CIN3), and group D (no CIN diagnosis) as a control group. Subsequently, cytofluorimetry and immunohistochemical analysis (based on the identified positive cell ratios as follows: ≤10%, negative; 10–25%, 1+ (weak); 25–50%, 2+ (medium); ≥50%, and 3+ (high)) for β1 integrin were carried out. <i>Results</i>: In total, 154 women were included. The average fluorescence intensity in the four groups was 2.35 ± 1.37, 2.73 ± 1.56, 3.09 ± 1.56, and 2.13 ± 1.25 UA from groups A to D, respectively; this figure was significantly different for CIN3 (group C) women relative to the other groups (<i>p</i> = 0.0132). Higher β1 integrin/CD29 concentrations in the CIN groups with HR-HPV 16 and 18 were also detected (<i>p</i> = 0.0292, 0.0367, and 0.0357 respectively for CIN3, CIN2, and CIN1). Immunohistochemistry analysis showed higher results for the CIN3 group compared to controls and all the other groups (<i>p</i> < 0.001). <i>Conclusions</i>: β1/CD29 integrin expression increased with CIN grade, and it was significantly higher in CIN3 lesions. This could be used as a promising screening tool to identify women prone to developing high-grade cervical lesions. However, additional evidence is needed to strengthen these findings.https://www.mdpi.com/1648-9144/60/3/364HPVintegrinscervical intraepithelial lesionCD29β1 integrincolposcopy |
| spellingShingle | Maria Teresa Schettino Eleonora Petra Preti Valeria Vietri Nadia Agrillo Nicola Iavazzo Diego Domenico Fasulo Pasquale De Franciscis Maria Rosaria Campitiello Maria Giovanna Vastarella Gaetano Riemma Barbara Gardella Filippo Murina The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions Medicina HPV integrins cervical intraepithelial lesion CD29 β1 integrin colposcopy |
| title | The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions |
| title_full | The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions |
| title_fullStr | The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions |
| title_full_unstemmed | The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions |
| title_short | The Role of β1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions |
| title_sort | role of β1 integrin cd29 as a potential prognostic factor for the risk of progression to cervical carcinoma in hpv associated lesions |
| topic | HPV integrins cervical intraepithelial lesion CD29 β1 integrin colposcopy |
| url | https://www.mdpi.com/1648-9144/60/3/364 |
| work_keys_str_mv | AT mariateresaschettino theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT eleonorapetrapreti theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT valeriavietri theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT nadiaagrillo theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT nicolaiavazzo theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT diegodomenicofasulo theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT pasqualedefranciscis theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT mariarosariacampitiello theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT mariagiovannavastarella theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT gaetanoriemma theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT barbaragardella theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT filippomurina theroleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT mariateresaschettino roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT eleonorapetrapreti roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT valeriavietri roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT nadiaagrillo roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT nicolaiavazzo roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT diegodomenicofasulo roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT pasqualedefranciscis roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT mariarosariacampitiello roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT mariagiovannavastarella roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT gaetanoriemma roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT barbaragardella roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions AT filippomurina roleofb1integrincd29asapotentialprognosticfactorfortheriskofprogressiontocervicalcarcinomainhpvassociatedlesions |